搜尋結果
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 5 日前The FTC sent warning letters to 10 pharmaceutical companies—including Novo Nordisk, ...
California Cuts Cost of Overdose-Reversal Drug by 40% in Generic Deal
Bloomberg· 5 日前... efforts to combat surging opioid-related deaths by teaming with a maker of generic< ... ...
Buy this 'dirt-cheap,' top-rated dividend stock with a 4% yield, Morningstar says
CNBC· 6 日前There's one dividend stock that Morningstar says is "deeply undervalued" right ...
Sandoz reaches agreement with Amgen over patent dispute
Reuters· 4 日前Swiss generic and biosimilar manufacturer Sandoz said on Tuesday it had reached an agreement with U.S ...
White House Aims to Reclassify Marijuana as Less Dangerous Drug - What’s News - WSJ Podcasts
The Wall Street Journal· 4 日前Annmarie Fertoli: The Biden administration wants to reclassify marijuana as a less dangerous ...
Pfizer to pay $25.5 mln to settle remaining Effexor XR antitrust claims
Reuters· 5 日前Pfizer has agreed to pay $25.5 million to resolve claims that its predecessor Wyeth conspired ...
Drugmaker Amneal agrees to $270 million U.S. opioid settlement
Reuters· 1 日前, opens new tab said on Friday it had reached a deal valued at more than $270 million to ...
Bayer must face US company's flea and tick drug antitrust lawsuit
Reuters· 3 日前, opens new tab must face a U.S. antitrust lawsuit accusing a former unit of the German company ...
Marketing Is Supposed To Be ‘Authentic,’ But What Does That Actually Look Like?
Forbes· 4 日前Many solo entrepreneurs have heard that they should embrace “authentic” marketing—where they ...
Global Inequities In Access To Drugs Costs Millions Of Lives Each Year
Forbes· 7 日前The World Health Organization estimates that at least one-third of the world’s population does ...